Total
0
Shares
RooLife Group (ASX:RLG) - Managing Director, Bryan Carr - The Market Herald
Managing Director, Bryan Carr
Source: The Market Herald
  • RooLife Group (RLG) and AFT Pharmaceuticals (AFP) have launched a New Zealand-branded online health and pharmacy store in China
  • The pharmacy store, labelled Kiwi Health, in an online marketplace for AFT's well-known portfolio of health and wellbeing products to be sold to consumers in China
  • It will be operated by RooLife and was launched on Alibaba's Tmall platform with the support of New Zealand Trade and Enterprise
  • The launch of Kiwi Health was in preparation for Alibaba's 11.11 Global Shopping Festival on November 11 which is the world's largest online shopping event
  • Both RooLife and AFT Pharmaceuticals are steady on the market with shares respectively trading for 4.3 cents and $4.65

RooLife Group (RLG) and AFT Pharmaceuticals (AFP) have launched a New Zealand-branded online health and pharmacy store in China.

The pharmacy store, labelled Kiwi Health, in an online marketplace for AFT Pharmaceuticals' well-known portfolio of health and wellbeing products to be sold to consumers in China.

It will be operated by RooLife and was launched on Alibaba's Tmall platform with the support of New Zealand Trade and Enterprise, the New Zealand Government's international business development agency.

"Our products have already secured a strong following with the local Chinese consumers living in New Zealand and Australia," AFT Pharmaceuticals Founder and CEO Dr Hartley Atkinson said.

"We believe the launch of our Tmall Global flagship store will further assist us in amplifying our online presence in the world's largest eCommerce market," he added.

The launch of Kiwi Health was in preparation for Alibaba's 11.11 Global Shopping Festival on November 11. This shopping festival is the world's largest online shopping event

"We look forward to marketing and selling [AFT Pharmaceuticals'] well-know, trusted portfolio of health and well-being products in the Chinese market on Alibaba's Tmall Global marketplace," RooLife Managing Director Bryan Carr said.

"We have seen the successes achieved by large Australian and New Zealand based pharmacy chains online in China and we are excited by the opportunity to leverage the high regard for New Zealand and its products with Chinese shoppers," he added.

Both RooLife and AFT Pharmaceuticals are steady on the market with shares trading for 4.3 cents and $4.65, respectively, at 10:52 am AEDT.


Subscribe


RLG by the numbers
More From The Market Herald
Spacetalk (ASX:SPA) - CEO, Mark Fortunatow - The Market Herald

" Harvey Norman to begin selling Spacetalk’s (ASX:SPA) namesake device

Spacetalk (SPA), formerly MGM Wireless, has revealed that Harvey Norman will begin selling the Spacetalk Kids device across its stores.
ImpediMed (ASX:IPD) - Managing Director & CEO, Rick Carreon - The Market Herald

" Impedimed’s (ASX:IPD) screening tech proves effective against BCRL

A data meta-analysis shows Impedimed’s (IPD) spectroscopy technology can reduce incidence rates of chronic breast cancer-related lymphoedema (BCRL).
Creso Pharma (ASX:CPH)  to benefit from new CBD E.U. ruling

" Creso Pharma (ASX:CPH) to benefit from new CBD E.U. ruling

Creso Pharma (CPH) shares are rising after a new ruling on cannabidiol (CBD) products, unlocking major potential for the company in Europe.
Telix Pharmaceuticals (ASX:TLX) - CEO, Dr Christian Behrenbruch - The Market Herald

" Telix Pharmaceuticals (ASX:TLX) eyes TheraPharma buy

Telix Pharmaceuticals (TLX) is set to buy Swiss-German biotech TheraPharm for €10.2 million (around A$16.5 million) upfront.